InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: FACT-MASTER post# 24

Sunday, 06/11/2023 9:28:25 AM

Sunday, June 11, 2023 9:28:25 AM

Post# of 110
They didn't say how phase 1 data will be presented. Primary endpoint of dose-escalation part of their study was finding a RP2D. They said it was done.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BDTX News